News

Futurae Technologies developed a hands-off two-factor user authentication system for online applications that require additional security. The startup was awarded 130'000 Swiss francs at the Venture Kick final and is now ready to conquer the market.

The Zurich based startup Perspective Robotics was announced as the winner of the first prize of the Entrepreneurship and TechTransfer award during the European Robotics Forum. The startup was recognised for its innovative aerial robotics design.

Biotech startup Numab Therapeutics specialising in proprietary pipeline of multi-specific biotherapeutics in immuno-oncology and immunology has entered a research and option agreement with Ono Pharmaceutical Co., Ltd. for the identification of a multi-specific antibody candidate for development in immuno-oncology.  Numab will receive up to CHF 258 million...

The START Summiteer Award ceremony was celebrated within the framework of the annual two-day START Summit in St. Gallen. Based on their innovativeness, the jury announced nanoleq as the winner of the award. The startup was rewarded a cash prize of CHF 20’000.

Les cinq start-ups finalistes du Prix Strategis, organisé par l’association d’étudiants HEC Espace Entreprise, ont été choisies lors de la deuxième réunion du Jury ce mardi 28 mars 2017 à Lausanne.

The funding round for the biotech start-up was led by Redalpine Venture Partners. The funding brings resources to advance Versantis’ lead candidate VS-01 to first-in-human study and transform the care of patients with rare and life-threatening liver diseases.

Swiss Startup Invest has completely redesigned its Swiss Venture Day to allow for more meetings, keynote speeches and startup pitches. 22 startups have been selected to pitch at the first reloaded event on 5. April 2017. Registration to attend the event is open until 1. April.

Vergangenes Jahr investierte die Zürcher Kantonalbank 9.5 Millionen Franken in insgesamt 27 Startups. Acht der Investments waren Neufinanzierungen.

Recent clinical study results of ProteoMediX’ prostate cancer test were presented at the 2017 Annual European Association of Urology Congress. It shows that the implementation of the test in clinical practice has the potential to significantly lower the rate of prostate biopsies which are negative for prostate cancer by more than 50%.

ESA BIC operates a technology transfer programme offering targeted support and funding to start-ups in the field of space technologies and applications. Last week seven start-ups were selected for the program.